Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the efficacy of 84 successive days of topically administered LHA510 compared to vehicle in reducing the number of patients requiring intravitreal (IVT) anti-va...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alcon, a Novartis Company
NCT07328776 · Exudative Age-Related Macular Degeneration, DME, and more
NCT05447650 · Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, and more
NCT04200248 · Exudative Age-related Macular Degeneration
NCT05703867 · Age-Related Macular Degeneration, Nonexudative Age-related Macular Degeneration
NCT02348359 · Age-Related Macular Degeneration (AMD), Macular Degeneration, and more
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions